You are currently viewing a new version of our website. To view the old version click .
International Journal of Molecular Sciences
  • Correction
  • Open Access

18 September 2024

Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586

,
,
,
,
,
and
1
Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway
2
Department of Clinical Cancer Research, Oslo University Hospital, 0424 Oslo, Norway
3
Faculty of Health Sciences, Oslo Metropolitan University, 0130 Oslo, Norway
*
Author to whom correspondence should be addressed.
In the original publication [], there was a mistake in Figure 6A. When the IVIS images of two mice in JK10 group day 17 were cropped from the original larger image to fit with the layout, a mistake occurred so that one JK10 mouse was replaced with a JK11 mouse. The analyzed data were correct; as were Figure 6B–D. Only the image of the individual mouse was wrong. The corrected Figure 6 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 6. CD28 and 4-1BB CAR T cells inhibit tumor growth in vivo. (A) Bioluminescence images of individual mice at multiple time points in a subcutaneous tumor model. NSG mice were engrafted subcutaneously on both hind legs with 2 × 106 luciferase expressing 22Rv1 prostate cancer cells. On days 10 and 17, the mice were treated with 1 × 107 non-transduced (NT) T cells (Ntumor = 6) or CD28 CAR T cells (Ntumor = 12) and 4-1BB CAR T cells (Ntumor = 12) by intravenous injection. Bioluminescence signals of individual mice were measured at indicated time points (days after tumor engraftment). (B) Tumor growth is measured once a week by bioluminescence IVIS imaging. The data are presented as the mean ± SEM of tumors in each group. (C) Bioluminescence signals (mean ± SEM) 38 days after tumor engraftment. Statistical analyses in (B,C) were performed with the Mann–Whitney U test. NS (not significant), ** p < 0.001. (D) The body weight of the mice was measured once per week after the first treatment with T cells on day 10. Error bars indicate SD.

Reference

  1. Jin, Y.; Dunn, C.; Persiconi, I.; Sike, A.; Skorstad, G.; Beck, C.; Kyte, J.A. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.